News related to Combivent (Ipratropium / Albuterol) and/or conditions it is approved for
Chronic Obstructive Pulmonary Disease
Source: MedicineNet Alpha 1 Antitrypsin Deficiency Specialty [2006.10.13]
Title: Chronic Obstructive Pulmonary Disease
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 10/13/2006
Fears Over Asthma Misdiagnosis Lead To British Lung Foundation Calls For Mass Retesting
Source: Health News from Medical News Today [2008.11.20]
The British Lung Foundation is calling for everyone over 35 with Asthma or the progressive illness Chronic Obstructive Pulmonary Disease (COPD) to be retested following evidence of confusion over diagnosis and treatment of the two respiratory diseases. A survey of 776 GPs from all over the UK carried out for the charity by Doctors.net.
World COPD Day 2008 Features New Initiatives That Drive Enhanced Diagnosis And Treatment
Source: Respiratory / Asthma News From Medical News Today [2008.11.18]
World COPD Day 2008 features new patient and health professional initiatives that address the misconceptions and lack of awareness surrounding chronic obstructive pulmonary disease (COPD).
Mpex Pharmaceuticals Presents New Data On MP-376 In Cystic Fibrosis
Source: Cystic Fibrosis News From Medical News Today [2008.10.24]
Mpex Pharmaceuticals, Inc. announced additional clinical and preclinical results with MP-376, the company's novel formulation of levofloxacin inhaled solution delivered by an Investigational eFlow Nebulizer System for use in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Clinical results show that aerosol dosing of MP-376 was well tolerated at all dose levels tested after 14 days of dosing.
|
